Question 1

What are the most cited papers from ImCyse (Belgium)?

Accepted Answer

The most cited paper from ImCyse (Belgium) is "First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes" (Jean Van Rampelbergh, Peter Achenbach, Richard David Leslie et al., 2023), with 28 citations. Next come "A future of AI-driven personalized care for people with multiple sclerosis" (24) and "Thioreductase-Containing Epitopes Inhibit the Development of Type 1 Diabetes in the NOD Mouse Model" (22).

Question 2

Which research topics does ImCyse (Belgium) publish most on?

Accepted Answer

By volume in 2022-now: Digital Media Forensic Detection, Anomaly Detection Techniques and Applications, Adversarial Robustness in Machine Learning and Diabetes and associated disorders.

Question 3

Which fields of science does ImCyse (Belgium) work in?

Accepted Answer

In all years, 45% of research at ImCyse (Belgium) is in Life Sciences, 27% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (27%), Medicine (27%), Business, Management and Accounting (19%). It does 1.4× the world's share of Life Sciences.

Question 4

Is ImCyse (Belgium)'s research output growing?

Accepted Answer

Output in 2022-2025 was 60% higher than in 2018-2021.